There is a version of the Roundup story that almost never gets told. It is not the farmer with the backpack sprayer or the landscaper who mixed concentrate every morning. It is the wife who shook out and washed his work clothes twice a week for twenty years. It is the child who rode in the cab of the truck and played in the freshly treated backyard. It is the family whose home sat at the edge of a field that was sprayed every spring. None of them ever bought a jug of Roundup. Some of them are now the ones with the diagnosis.
The Exposure Group Nobody Writes About
Our other guides walk through the classic exposure categories: agricultural workers and applicators, professional landscapers and groundskeepers, and homeowners who used Roundup in their own yards. Every one of those assumes the injured person did the spraying. This piece is about the people who did not, and it fills a real gap, because that group is larger than the coverage suggests and its cases are the least understood.
Non-applicator exposure sorts into three broad pathways. Take-home exposure reaches the family of an applicator through residue carried into the house. Bystander exposure reaches people who were physically present while someone else sprayed. Residential-proximity exposure reaches people who lived, worked, or went to school near land that was treated regularly. The three overlap in real life, and a single person often has more than one of them. What they share is the same central problem: the exposed person was not the one who controlled the product, so the case has to be built from the world around them.
Take-Home Exposure: The Residue That Rides Home on Work Clothes
Take-home exposure, which occupational-health researchers call para-occupational exposure, is a well-documented pathway for workplace chemicals in general. It happens when a worker unintentionally carries residue off the job on skin, hair, clothing, boots, and vehicle upholstery, and that residue then spreads through the home. The National Institute for Occupational Safety and Health (NIOSH) first raised the alarm in a 1995 report finding that workers' homes across dozens of U.S. states and many countries were contaminated with workplace substances, pesticides among them. In a 2020 update, NIOSH concluded plainly that "take-home exposures still persist."
For agricultural chemicals specifically, the pathway is well enough accepted that the law addresses it. The U.S. Environmental Protection Agency's Worker Protection Standard, revised in 2015, requires that agricultural workers be trained on the risk of taking pesticide residue home and on washing and storing work clothes separately from the family's laundry. A rule that tells workers to keep their clothes out of the household wash exists precisely because regulators recognize that the clothes carry something the family should not be breathing or touching. NIOSH has noted that children of agricultural workers are thought to be exposed to pesticides largely through this take-home route.
Honesty requires a caveat here, and it is one competitors tend to skip. The biomonitoring evidence for take-home glyphosate specifically is more mixed than for older pesticides like organophosphates. A 2022 family biomonitoring study in Ireland (the IMAGE project) detected glyphosate's breakdown product, AMPA, in 61 percent of urine samples and glyphosate in 32 percent, with the applicator fathers showing the highest levels — but it did not find that spouses and children of applicators had statistically higher levels than non-farm families, and the concentrations it measured were low. That study is one data point, in one country, at one moment in time. It does not disprove take-home exposure; it shows the picture is not uniform and that each family's actual exposure has to be assessed on its own facts rather than assumed.
Bystander Exposure: Present When Someone Else Sprayed
Bystander exposure is more intuitive. A review of glyphosate and non-Hodgkin lymphoma in Clinical Lymphoma, Myeloma & Leukemia noted that beyond applicators themselves, "homeowners and bystanders may be heavily exposed to glyphosate-based formulations during application, mainly by dermal and inhalation exposures." In plain terms: you do not have to hold the wand to breathe the mist or get it on your skin. A spouse standing nearby, a farmhand working the next row, a child in the yard during application, a groundskeeping helper who never personally operated the sprayer — all can absorb product from spray drift, from re-entering a treated area too soon, or from contact with wet foliage.
Bystander cases turn on the specifics: how close the person was, how often they were present, whether application happened indoors or in an enclosed area, wind and drift conditions, and whether protective distance or timing was observed. Those details are exactly the sort of thing a careful exposure reconstruction pins down, and they are why two people who both describe themselves as "bystanders" can have very different cases.
Residential-Proximity Exposure: Living Next to Treated Land
The third pathway is the hardest of the three, and we say so up front. Living near sprayed agricultural land, golf courses, orchards, or right-of-way vegetation can produce measurable environmental exposure through drift and dust. Human biomonitoring studies have repeatedly shown that glyphosate and AMPA are detectable in the general population, which tells us that background environmental exposure is real and widespread. Some proximity research has found associations between residence near agricultural fields and elevated risk of certain cancers — a 2025 case-control study in Argentina, for example, linked residential proximity to agricultural fields and urinary glyphosate levels with breast cancer risk.
But we do not overstate this. The strongest and most consistent epidemiological signal tying glyphosate to non-Hodgkin lymphoma comes from the most heavily exposed groups, the applicators, not from low-level environmental proximity. A proximity theory standing alone is a difficult case. It becomes meaningful when it is one layer among several — combined, for instance, with years of duration, very close distance, repeated seasonal spraying, a qualifying diagnosis, and the absence of stronger competing explanations. Proximity is a factor in the analysis, not a shortcut around it.
What the Underlying Cancer Science Says
None of these pathways matters unless glyphosate can cause the cancer in the first place, and that question is the same one at the heart of every Roundup case. In 2015, the World Health Organization's International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" (Group 2A) in Monograph Volume 112. In 2019, a meta-analysis led by Dr. Luoping Zhang of the University of California, Berkeley, published in Mutation Research/Reviews in Mutation Research, focused on the most highly exposed individuals across the available studies and reported a 41 percent increased relative risk of non-Hodgkin lymphoma, describing what the authors called a "compelling link." The U.S. EPA has reached a different regulatory conclusion, which is the long-running disagreement between IARC and the EPA that runs through this entire area of litigation.
Two things follow for the non-applicator. First, the causation science that supports an applicator's claim is the same science available to a family member or bystander — the biology of how the substance is thought to act does not change based on who was standing where. Second, because the clearest human evidence comes from heavy exposure, the strength of a non-applicator case rises and falls on how well the actual exposure can be shown to have been meaningful rather than trivial. That is a documentation problem, and documentation is something a case can work on.
Why the Design-Defect Theory Still Reaches These Cases
There is a legal reason the non-applicator matters especially now. After the Supreme Court's 2026 decision in Monsanto v. Durnell, much of the public debate has centered on the product label and the duty to warn the user. We wrote about why that is not the whole story in our look at strict liability versus failure-to-warn. The theory The Alvarez Law Firm leads with is design defect: the argument that the product was unreasonably dangerous as formulated, regardless of what any label said.
That distinction is doubly relevant to a bystander or a family member, because a warning on a jug is aimed at the person reading the jug — the buyer, the applicator. The wife washing the clothes never read the label; the child in the yard never read the label. A theory built on the adequacy of a warning to the user is a poor fit for someone who was exposed without ever being the user. A design-defect theory, which asks whether the formulation itself was defective, does not depend on who read the warning. As always, whether that theory fits a specific set of facts is a case-by-case question governed by the law of the relevant state.
How a Non-Applicator Case Actually Gets Built
Because the injured person did not buy or control the product, the evidence comes from the people and records around the exposure. In practice, evaluating one of these cases means gathering things like:
- The applicator's history, not just yours. For a take-home case, the spouse's or parent's work history, the products they used, and how long they used them are the foundation. Our guide on product identification across multiple glyphosate products applies here too — identifying what was actually used is often step one.
- The geography and the routine. Where the home, yard, school, or workplace sat relative to treated land; how residue moved through the house; who did the laundry and how; whether the treated area was re-entered while still wet.
- Witnesses. Family members, co-workers, and neighbors who can describe how, where, and how often spraying happened, and how the exposed person came into contact with it.
- The diagnosis, read carefully. A clearly established qualifying cancer — non-Hodgkin lymphoma and its subtypes chief among them — with the pathology and treatment records that pin it down. On our team, Herb Borroto, M.D., J.D., reads that material himself.
- The competing explanations. An honest evaluation looks at other risk factors too, because a case that ignores them is a case built to fail.
We are candid with people about the trade-off. A non-applicator case usually carries a harder exposure-proof burden than a career applicator's case. That does not make it a weak case; it makes it a case that has to be reconstructed with care instead of assumed. Whether yours can move forward depends on the facts and on the theories available where you live — the same message we give every caller, applicator or not. Our overview of who qualifies for a Roundup lawsuit is the companion piece to this one.
Frequently Asked Questions
Can I file a Roundup lawsuit if I never sprayed it myself?
Possibly. Being the person who held the sprayer is not a legal requirement. What matters is whether you had a meaningful, documentable exposure to a glyphosate-based product and later developed a qualifying cancer such as non-Hodgkin lymphoma. Non-applicators fall into three general groups: family members exposed through an applicator's contaminated clothing and vehicles (take-home exposure), people present while someone else sprayed (bystander exposure), and people who lived or worked near regularly treated land. These cases are more fact-dependent than an applicator's case, so whether one can proceed depends on the specific exposure history, the diagnosis, and the law of the relevant state.
What is take-home or para-occupational pesticide exposure?
Take-home exposure, also called para-occupational exposure, happens when a worker unintentionally carries chemical residue from a job site into the home on skin, hair, work clothes, boots, and vehicle seats. The National Institute for Occupational Safety and Health has documented this pathway for pesticides and other workplace chemicals since a 1995 report, and children of agricultural workers are thought to be exposed to pesticides largely through this route. The federal Worker Protection Standard now requires training on washing and storing work clothing separately from household laundry.
Does living near a sprayed field prove my cancer was caused by glyphosate?
No single fact proves causation by itself, and residential proximity alone is one of the harder exposure theories. Biomonitoring research shows glyphosate and its breakdown product AMPA are widely detectable in the general population, and some proximity studies have found associations with certain cancers, but the strongest epidemiological signal for non-Hodgkin lymphoma comes from the most heavily exposed applicators. Proximity is evaluated as one piece of a larger picture that also includes duration, how close and how often, the diagnosis, and other risk factors.
How do you prove exposure when I was not the one buying or spraying the product?
The proof comes from the same categories of evidence used in any product case, gathered from the people and records around the exposure rather than from the injured person's own purchases. That can include a spouse's or parent's work and product history, employer and application records, witness accounts of how and where spraying was done, residence and school locations relative to treated land, and the medical records establishing the diagnosis. Because the injured person did not control the product, reconstructing the exposure carefully is the central task of a non-applicator case.
Bottom Line
The person who never touched a jug of Roundup is the exposure story the headlines leave out. Take-home residue on a spouse's work clothes, drift from a sprayer held by someone else, and life next to land that was treated season after season are all real pathways, grounded in decades of occupational-health research and, for glyphosate, in a body of science that is strong in places and still developing in others. We do not oversell any of it. What we do is read the exposure and the diagnosis honestly and tell you where a case stands. If you or a family member developed Non-Hodgkin Lymphoma, B-cell Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and the exposure came secondhand, that is not a reason to assume you have no case — it is a reason to have the facts read by people who know what to look for.
At our firm, Herb Borroto, M.D., J.D., reads the pathology, the immunohistochemistry, and the oncology charts himself, and Alex Alvarez, Managing Partner and Board Certified Civil Trial Lawyer, evaluates which legal theory the exposure history can support. The free case review is exactly what it says: no obligation, and no fee unless we recover for you.